ENANTA PHARMACEUTICALS INC Quarterly Debt-to-equity in % from Q4 2013 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Enanta Pharmaceuticals Inc quarterly Debt-to-equity history and growth rate from Q4 2013 to Q3 2024.
  • Enanta Pharmaceuticals Inc Debt-to-equity for the quarter ending September 30, 2024 was 154 %, a 161% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 154 +95.2 +161% Sep 30, 2024
Q2 2024 135 +98.6 +268% Jun 30, 2024
Q1 2024 121 +105 +628% Mar 31, 2024
Q4 2023 87 +72.1 +485% Dec 31, 2023
Q3 2023 59.2 +44.5 +304% Sep 30, 2023
Q2 2023 36.8 +23.9 +185% Jun 30, 2023
Q1 2023 16.7 +5.37 +47.5% Mar 31, 2023
Q4 2022 14.9 +5.11 +52.3% Dec 31, 2022
Q3 2022 14.7 +6.89 +88.5% Sep 30, 2022
Q2 2022 12.9 +5.87 +83.5% Jun 30, 2022
Q1 2022 11.3 +4.59 +68.4% Mar 31, 2022
Q4 2021 9.76 +3.45 +54.7% Dec 31, 2021
Q3 2021 7.78 +1.59 +25.7% Sep 30, 2021
Q2 2021 7.03 +1.03 +17.2% Jun 30, 2021
Q1 2021 6.71 +0.92 +15.9% Mar 31, 2021
Q4 2020 6.31 +0.47 +8.05% Dec 31, 2020
Q3 2020 6.19 +0.24 +4.04% Sep 30, 2020
Q2 2020 6 +0.21 +3.63% Jun 30, 2020
Q1 2020 5.8 +0.14 +2.48% Mar 31, 2020
Q4 2019 5.84 +0.07 +1.21% Dec 31, 2019
Q3 2019 5.95 +0.03 +0.51% Sep 30, 2019
Q2 2019 5.79 -0.88 -13.2% Jun 30, 2019
Q1 2019 5.66 -1.29 -18.6% Mar 31, 2019
Q4 2018 5.77 -0.87 -13.1% Dec 31, 2018
Q3 2018 5.91 +0.16 +2.78% Sep 30, 2018
Q2 2018 6.66 +2.02 +43.5% Jun 30, 2018
Q1 2018 6.95 +2.53 +57.2% Mar 31, 2018
Q4 2017 6.63 +2.01 +43.5% Dec 31, 2017
Q3 2017 5.75 +0.75 +15% Sep 30, 2017
Q2 2017 4.65 -0.38 -7.56% Jun 30, 2017
Q1 2017 4.42 -0.47 -9.62% Mar 31, 2017
Q4 2016 4.63 -1.16 -20.1% Dec 31, 2016
Q3 2016 5.01 -2.1 -29.5% Sep 30, 2016
Q2 2016 5.03 -2.48 -33.1% Jun 30, 2016
Q1 2016 4.89 -2.99 -37.9% Mar 31, 2016
Q4 2015 5.78 -1.2 -17.2% Dec 31, 2015
Q3 2015 7.11 +2.29 +47.5% Sep 30, 2015
Q2 2015 7.5 +2.35 +45.6% Jun 30, 2015
Q1 2015 7.88 +2.56 +48.2% Mar 31, 2015
Q4 2014 6.98 +1.72 +32.7% Dec 31, 2014
Q3 2014 4.82 Sep 30, 2014
Q2 2014 5.16 Jun 30, 2014
Q1 2014 5.32 Mar 31, 2014
Q4 2013 5.26 Dec 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.